Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone

OBJECTIVE: Prostate cancer (PCa) is the second most common male malignancy globally. Prostate-specific antigen (PSA) is an important biomarker for PCa diagnosis. However, it is not accurate in the diagnostic gray zone of 4–10 ng/ml of PSA. In the current study, the performance of serum metabolomics...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Bei, Chen, Yan, Chen, Xi, Gan, Lingling, Zhang, Yamei, Feng, Jiafu, Yu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554118/
https://www.ncbi.nlm.nih.gov/pubmed/34722271
http://dx.doi.org/10.3389/fonc.2021.730638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554118/
https://www.ncbi.nlm.nih.gov/pubmed/34722271
http://dx.doi.org/10.3389/fonc.2021.730638

Ejemplares similares